UK Tuberculosis Diagnosis and Treatment Market Trends, Growth, Industry Analysis and Forecast 2025

UK tuberculosis diagnosis and treatment market are anticipated to grow at a CAGR around 0.8% during the forecast period. Early stages can be difficult to detect in the case of tuberculosis due to which the diagnostic and treatment can be delayed. Almost all forms of TB are treatable and curable; however, delays in diagnosis and treatment can result in less favorable outcomes for the individual and possible spread TB infection to other people. Tuberculosis screening test can be defined in many ways. The UK National Screening Committee is responsible for population screening and runs the national NHS screening programmers. It defines screening as a process of identifying apparently healthy people who are at increased risk of a tuberculosis disease or condition.

Get Sample Copy of UK Tuberculosis Diagnosis and Treatment Market at: https://www.omrglobal.com/request-sample/uk-tuberculosis-diagnosis-treatment-market

The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline PLC, Johnson & Johnson, Pifzer, Inc., Epistem Holdings PLC, Novartis AG, Cepheid Inc. and Qiagen AG among other.

There are various types of screening for TB, including those aimed at detecting latent TB infection in people without symptoms, and those aiming to detect early active TB stage. These TB screening initiatives are not currently managed by the UK National Screening Committee, however, LTBI screening is recommended by NICE (National Institute for Health and Care) for people at higher risk of TB. The factors which have been contributing in the growth of the tuberculosis diagnostic and treatment market in UK are raising awareness among professionals and the public, or through active case finding of TB affecting the lungs. LTBI screening and active case finding support each other as public health activities which is also contributing in the growth of the market in the UK.

For More Information, get A full report of UK Tuberculosis Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/uk-tuberculosis-diagnosis-treatment-market

UK tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Market Segmentation

Tuberculosis Diagnosis and Treatment Market by Drugs Type

o First Line Drugs
o Second Line Drugs

Tuberculosis Diagnosis and Treatment Market by Diagnosis

o Laboratory Testing
o Nucleic Acid Amplification Test
o Mantoux Test
o Radiography
o Drug Susceptibility Testing

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-tuberculosis-diagnosis-treatment-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.